Clinical Trial Update: MCRcI® Stem Cell Treatment for Diffuse Coronary Artery Disease [Phase 1]

View source ↗

Summary

This document provides a Phase 1 clinical trial status update for MCRcI® stem cell treatment in diffuse coronary artery disease, noting that recruitment has not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• MCRcI® Stem Cell Treatment

Snippet

Sponsor: Honya Medical Inc | Conditions: Coronary Artery Disease | Phase 1 | Status: NOT_YET_RECRUITING